Emergent Biosolutions (EBS) Stock Price, Quote & News

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax va...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 240 631 3200

Website: www.emergentbiosolutions.com

Address:

300 Professional Drive, Gaithersburg, United States

KnuckleSandwich Nov. 14 at 8:42 PM

$EBS when Q4 2025 Narcan sales hit above the high point of the projected range EBS will immoderately be trading 25+

0 · Reply

alwayzwong Nov. 14 at 8:37 PM

$EBS we would have been at $20 or so this year, if it weren’t from that drop in narcan revs. We will get to $20 though next year

0 · Reply

KnuckleSandwich Nov. 14 at 8:25 PM

$EBS it's amazing how much money is in the market manipulation game to get the option boys paid...never though the 10$ calls even had a chance to get paid but the large position between 13-10 strike price a manipulating everything.

0 · Reply

alwayzwong Nov. 14 at 8:24 PM

$EBS that he says and that he does are two different things. However, we are headed in the right direction and it has been a long time since this start of this chit show

0 · Reply

KnuckleSandwich Nov. 14 at 8:21 PM

$EBS get me some of that drug money! https://x.com/YahooNews/status/1989423213013590033?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

0 · Reply

Rolltide2020 Nov. 14 at 8:09 PM

$EBS Need to get this bish to $10.33 or higher to stay above 20 day.

0 · Reply

KnuckleSandwich Nov. 14 at 7:35 PM

$EBS let’s get paid 💥💪🏼

0 · Reply

Polip Nov. 14 at 7:35 PM

$EBS Liquidity! https://www.nytimes.com/2025/11/14/health/purdue-sacklers-settlement.html?smid=nytcore-ios-share&referringSource=articleShare

0 · Reply

ComradeKomisar Nov. 14 at 7:33 PM

$EBS Finally! That took 84 years.

2 · Reply

Kazoonova Nov. 14 at 7:23 PM

$EBS

0 · Reply

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Nov 6, 2025, 11:00 PM EST - 7 days ago

Emergent BioSolutions: Solid Q3, Expecting Better Days To Come

Oct 29, 2025, 8:56 PM EDT - 15 days ago

Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:15 PM EDT - 16 days ago

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

Oct 28, 2025, 8:00 AM EDT - 17 days ago

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

Oct 8, 2025, 7:45 AM EDT - 5 weeks ago

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Sep 24, 2025, 4:05 PM EDT - 7 weeks ago

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

Sep 19, 2025, 8:34 AM EDT - 2 months ago

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

Sep 15, 2025, 8:35 AM EDT - 2 months ago

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

Sep 9, 2025, 7:30 AM EDT - 2 months ago

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Sep 2, 2025, 7:40 AM EDT - 2 months ago

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Aug 29, 2025, 8:05 AM EDT - 2 months ago

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Aug 27, 2025, 8:01 AM EDT - 2 months ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Aug 21, 2025, 8:45 AM EDT - 3 months ago

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

Aug 12, 2025, 12:46 PM EDT - 3 months ago

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

Aug 7, 2025, 7:31 PM EDT - 3 months ago

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:15 PM EDT - 3 months ago

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Jul 28, 2025, 8:50 AM EDT - 3 months ago

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

Jul 28, 2025, 8:50 AM EDT - 3 months ago

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Jul 15, 2025, 7:30 AM EDT - 4 months ago

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 8, 2025, 4:45 PM EDT - 4 months ago

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Jul 2, 2025, 4:05 PM EDT - 4 months ago

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Jun 23, 2025, 8:05 AM EDT - 5 months ago

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Jun 20, 2025, 2:25 PM EDT - 5 months ago

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Jun 20, 2025, 8:13 AM EDT - 5 months ago

Emergent BioSolutions Announces Addition to Russell 3000® Index

Jun 5, 2025, 7:00 AM EDT - 5 months ago

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

May 7, 2025, 10:01 PM EDT - 6 months ago

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 6 months ago

Emergent BioSolutions Reports First Quarter 2025 Financial Results

May 1, 2025, 5:07 PM EDT - 7 months ago

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Apr 22, 2025, 8:00 AM EDT - 7 months ago

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Mar 31, 2025, 8:00 AM EDT - 8 months ago

Emergent BioSolutions Announces Stock Repurchase Program

Mar 20, 2025, 4:30 PM EDT - 8 months ago

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Mar 20, 2025, 8:06 AM EDT - 8 months ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Mar 19, 2025, 4:30 PM EDT - 8 months ago

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 18, 2025, 8:00 AM EDT - 8 months ago

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Mar 13, 2025, 8:29 AM EDT - 8 months ago

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Mar 10, 2025, 9:14 AM EDT - 8 months ago

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 3, 2025, 7:58 PM EST - 9 months ago

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 4:23 PM EST - 9 months ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 18, 2025, 8:55 AM EST - 9 months ago

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 7, 2025, 8:06 AM EST - 10 months ago

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Jan 16, 2025, 8:00 AM EST - 10 months ago

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Jan 14, 2025, 7:53 AM EST - 10 months ago

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Jan 14, 2025, 7:30 AM EST - 10 months ago

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Jan 13, 2025, 9:27 AM EST - 10 months ago

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Jan 8, 2025, 7:45 AM EST - 11 months ago

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Jan 8, 2025, 7:30 AM EST - 11 months ago

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

Dec 2, 2024, 5:49 PM EST - 1 year ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

SIGA

Nov 8, 2024, 9:25 AM EST - 1 year ago

Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic

KnuckleSandwich Nov. 14 at 8:42 PM

$EBS when Q4 2025 Narcan sales hit above the high point of the projected range EBS will immoderately be trading 25+

0 · Reply

alwayzwong Nov. 14 at 8:37 PM

$EBS we would have been at $20 or so this year, if it weren’t from that drop in narcan revs. We will get to $20 though next year

0 · Reply

KnuckleSandwich Nov. 14 at 8:25 PM

0 · Reply

alwayzwong Nov. 14 at 8:24 PM

$EBS that he says and that he does are two different things. However, we are headed in the right direction and it has been a long time since this start of this chit show

0 · Reply

KnuckleSandwich Nov. 14 at 8:21 PM

$EBS get me some of that drug money! https://x.com/YahooNews/status/1989423213013590033?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet

0 · Reply

Rolltide2020 Nov. 14 at 8:09 PM

$EBS Need to get this bish to $10.33 or higher to stay above 20 day.

0 · Reply

KnuckleSandwich Nov. 14 at 7:35 PM

$EBS let’s get paid 💥💪🏼

0 · Reply

Polip Nov. 14 at 7:35 PM

$EBS Liquidity! https://www.nytimes.com/2025/11/14/health/purdue-sacklers-settlement.html?smid=nytcore-ios-share&referringSource=articleShare

0 · Reply

ComradeKomisar Nov. 14 at 7:33 PM

$EBS Finally! That took 84 years.

2 · Reply

Kazoonova Nov. 14 at 7:23 PM

$EBS

0 · Reply

ComradeKomisar Nov. 14 at 7:18 PM

$EBS we are going bankrupt!

1 · Reply

alwayzwong Nov. 14 at 7:14 PM

$EBS wat dis mean?

1 · Reply

Kazoonova Nov. 14 at 7:13 PM

$EBS Lowest I've ever seen the borrow rate.

0 · Reply

ComradeKomisar Nov. 14 at 7:07 PM

$EBS 100K to go

0 · Reply

Rolltide2020 Nov. 14 at 6:51 PM

$EBS I hear MOSA Panther results should be out in the 1st quarter of 2025.

1 · Reply

ComradeKomisar Nov. 14 at 6:43 PM

$EBS Everyone is trading dopetions, except for me.

0 · Reply

Kazoonova Nov. 14 at 6:41 PM

$EBS Crazy to think this was attempting to break $11 yesterday and now it's barely clinging to $10.

1 · Reply

SuperGreenToday Nov. 14 at 6:40 PM

$EBS Share Price: $10.11 Contract Selected: Mar 20, 2026 $10 Calls Buy Zone: $1.36 – $1.68 Target Zone: $2.39 – $2.93 Potential Upside: 66% ROI Time to Expiration: 125 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Jamespaizen Nov. 14 at 6:16 PM

$EBS bought a bunch at 10.25, 10.27

1 · Reply

Rolltide2020 Nov. 14 at 6:09 PM

$EBS Cuz this makes sense

0 · Reply

alwayzwong Nov. 14 at 5:59 PM

$EBS SELL, SELL, SELL

0 · Reply

HedgeAlerts Nov. 14 at 5:44 PM

Hedge Alert Live - Protect Your Portfolio Contract: $EBS $10.00 Put · NOV 21, 2025 Exp Entry Price: $0.35 - $0.45 Exit Price Target: $1.06 Profit Margin: +135% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

Market Cap	567.74M
Revenue (ttm)	1.04B
Net Income (ttm)	-190.60M
EPS (ttm)	N/A
PE Ratio	5.49
Forward PE	9.14
Profit Margin	-18.26%
Debt to Equity Ratio	1.14

Volume	1,136,365
Avg Vol	1,150,116
Day's Range	N/A - N/A
Shares Out	52.52M
Stochastic %K	21%
Beta	2.06
Analysts	Sell
Price Target	$13.50